Lumedica Vision Inc., a Durham-based company that creates light-based scientific and medical instruments that deliver accurate diagnostic results, raised $100,000 in a simple agreement for future equity, according to a filing with the Securities and Exchange Commission.

Lumedica filed the Form D on March 6. The company did not specify what it intends to do with the proceeds.

Lumedica creates biomedical and scientific imaging products, systems and technologies that improve health care for the greatest number of patients and providers worldwide.

Lumedica makes diagnostic devices cheaper, more durable, and easier to disseminate.

In November 2018, New York state’s Luminate NY accelerator announced Lumedica as a finalist selected to receive an initial investment of $100,000 and take part in the second cohort.

The six-month program will assist the finalists with their ideas to accelerate the commercialization of their products. The teams will then compete on Demo Day following those six months, where they will compete for over $2 million in follow-on funding.

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.

The form can be found here.